171
Participants
Start Date
August 10, 2011
Primary Completion Date
September 25, 2017
Study Completion Date
September 25, 2017
agalsidase alfa
"Cohort 1: 0.2 mg/kg body weight administered as an intravenous (IV) infusion over 40 minutes every other week (EOW)~Cohort 2: 0.2 mg/kg body weight administered as an intravenous (IV) infusion over 40 minutes weekly"
Alberta Children's Hospital, Calgary
University of Alberta Hospital, Edmonton
Vancouver General Hospital, Vancouver
University of Manitoba, Winnipeg
Queen Elizabeth II Health Sciences Centre, Halifax
Izaak Walton Killam (IWK) Health Centre, Halifax
Kingston General Hospital, Kingston
London Health Sciences Centre - Victoria Hospital, London
The Hospital for Sick Children, Toronto
The Fred A. Litwin Family Centre in Genetic Medicine, Toronto
Hopital du Sacre-Coeur de Montreal, Montreal
Centre Hospitalier Universitaire de Sherbrooke (CHUS), Sherbrooke
Lead Sponsor
Shire
INDUSTRY